ARCHIVES

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions

November 4, 1983

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

NCI Reorganization Task Forces Near Decisions On New Division’s Makeup; Terry May Be Canidate

May 25, 1979

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

January 22, 1993

Breast Cancer Death Rates Improving, NCI Says

May 10, 1996

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002